Attached files

file filename
8-K - 8-K - IMAX CORPd573527d8k.htm

IMAX CORPORATION

Exhibit 99.1

 

LOGO

IMAX CORPORATION

2525 Speakman Drive

Mississauga, Ontario, Canada L5K 1B1

Tel: (905) 403-6500 Fax: (905) 403-6450

www.imax.com

IMAX CORPORATION REPORTS SECOND QUARTER 2013 FINANCIAL RESULTS

HIGHLIGHTS

 

   

Second quarter 2013 revenues increase 17% from prior year period to $82.3 million, driven by recurring revenue

 

   

Network growth and strong per screen averages drive 27% box office growth in Q2 2013 from prior year period

 

   

Strong second quarter signings, combined with recent CJ CGV and Wanda/AMC deals, position IMAX well for future footprint expansion

NEW YORK, NY – July 25, 2013 – IMAX Corporation (NYSE:IMAX; TSX:IMX) today reported second quarter 2013 revenues of $82.3 million, adjusted EBITDA as calculated in accordance with the Company’s credit facility of $32.2 million, adjusted net income of $15.0 million, or $0.22 per diluted share, and reported net income of $11.8 million, or $0.17 per diluted share.

“In the second quarter we remained focused on executing our strategy of expanding the network and delivering solid global box office and per screen performance, which resulted in strong recurring revenue growth,” said Richard L. Gelfond, IMAX Chief Executive Officer. “Strategic investments - including our innovative laser projection system - along with some non-recurring items, contributed to higher operating expenses in the quarter.”

“When you take into account the healthy backlog at the end of the second quarter, along with the substantial signing activity over the past few weeks, including last night’s Wanda/AMC announcement, the result is a strong pipeline for continued network expansion over the coming years,” Gelfond continued. “We believe that this, together with our world-class brand and our increasing ability to tailor our programming globally, positions the Company well for long-term growth and an exciting future.”

Network Growth Update

The total IMAX® theatre network consisted of 767 systems as of June 30, 2013, of which 634 were in commercial multiplexes. There were 284 theatre systems in backlog as of June 30, 2013, compared to 280 theatre systems in backlog as of June 30, 2012. With the inclusion of the recently announced 35 theatre agreement with CJ CGV as well as the 45 to 130 theatre agreement with Wanda/AMC, the Company’s total year-to-date signings are between 140 and 225, depending on whether Wanda/AMC exercises their option for 80 additional theatres under their most recent agreement. For a breakdown of theatre system signings, installations, network and backlog by type, please see the end of this press release.

In the second quarter of 2013, the Company signed contracts for 34 theatre systems, of which 25 were in new theatre locations and 9 were a combination of signings for laser systems and upgrades of certain of the Company’s film theatres to digital systems in existing theatre locations. In the quarter, the Company installed 30 theatre systems, of which 29 were in new theatre locations.

 

1


Second-Quarter Segment Results

 

   

Revenue from sales and sales-type leases was $17.1 million in the second quarter of 2013, compared to $14.9 million in the second quarter of 2012, primarily reflecting the installation of 11 full, new theatre systems under sales and sales-type lease arrangements in the most recent second quarter, the same number of theatre installs the Company booked this period last year, and the recognition of revenue related to previously installed digital upgrades. The Company also installed 1 digital system upgrade under a sales arrangement in the second quarter of 2013, compared to zero such upgrades in the second quarter of 2012.

 

   

Revenue from joint revenue-sharing arrangements was $18.3 million in the quarter, compared to $15.6 million in the prior-year period. During the quarter, the Company installed 18 new theatres under joint revenue-sharing arrangements, compared to 9 in the year-ago period. The Company had 336 theatres operating under joint revenue-sharing arrangements as of June 30, 2013, as compared to 274 theatres one year prior.

 

   

Production and IMAX DMR® (Digital Re-Mastering) revenues were $26.0 million in the second quarter of 2013, compared to $19.7 million in the second quarter of 2012. Gross box office from DMR titles was $219.7 million in the second quarter of 2013, compared to $173.5 million in the prior-year period. The average global DMR box office per screen in the second quarter of 2013 was $353,300, compared to $341,900 in the prior-year period.

Conference Call

The Company will host a conference call today at 8:30 AM ET to discuss its second quarter 2013 financial results. To access the call via telephone, interested parties should dial (800) 820-0231 approximately 5 to 10 minutes before it begins. International callers should dial (416) 640-5926. The participant passcode for the call is 1118760. This call is also being webcast by Thomson Financial and can be accessed on the ‘Investor Relations’ section of www.imax.com. A replay of the call will be available via webcast on the ‘Investor Relations’ section of www.imax.com or via telephone by dialing (888) 203-1112 (US and Canada) or (647) 436-0148 (international). The Conference ID for the telephone replay is 1118760.

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX theatres to connect with audiences in extraordinary ways, and, as such, IMAX’s network is among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto and Los Angeles, with offices in London, Tokyo, Shanghai and Beijing. As of June 30, 2013, there were 767 IMAX theatres (634 commercial multiplexes, 19 commercial destinations and 114 institutions) in 54 countries.

IMAX® , IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience® and IMAX Is Believing® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

###

This press release contains forward looking statements that are based on IMAX management’s assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, general economic, market or business conditions; the opportunities (or lack thereof) that may be presented to and pursued by the Company; the performance of IMAX DMR films; competitive actions by other companies; conditions in the in-home and out-of-home entertainment industries; the signing of theater system agreements; changes in laws or regulations; conditions, changes and developments in the commercial exhibition industry; the failure to convert theater system backlog into revenue; risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company’s growth and operations in China; the failure to respond to change and advancements in digital technology; risks related to the acquisition of AMC Entertainment Holdings, Inc. by Dalian Wanda Group Co., Ltd.; risks related to new business initiatives; the potential impact of increased competition in the markets within

 

2


which the Company operates; risks related to the Company’s inability to protect the Company’s intellectual property; risks related to Eastman Kodak bankruptcy and the possibility of constrained film supply; risks related to the Company’s implementation of a new enterprise resource planning system; risks related to the Company’s prior restatements and the related litigation; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

For additional information please contact:

 

Investors:

IMAX Corporation, New York

Teri Loxam

212-821-0100

tloxam@imax.com

 

Business Media:

Sloane & Company, New York

Whit Clay

212-446-1864

wclay@sloanepr.com

  

Media:

IMAX Corporation, New York

Ann Sommerlath

212-821-0155

asommerlath@imax.com

 

Entertainment Media:

Principal Communications Group, Los Angeles

Melissa Zuckerman/Paul Pflug

323-658-1555

melissa@pcommgroup.com

paul@pcommgroup.com

 

3


Additional Information

Theatre Network Details:

Signings and Installations

 

June 30, 2013

     Three Months  
     Ended June 30,  
     2013     2012  

Theatre Signings:

    

Full new sales and sales-type lease arrangements

     18 (1)      10   

New joint revenue sharing arrangements

     7        28   
  

 

 

   

 

 

 

Total new theatres

     25        38   

Upgrades of IMAX theatre systems

     9 (2)(3)      2   
  

 

 

   

 

 

 

Total Theatre Signings

     34        40   
  

 

 

   

 

 

 
     Three Months  
     Ended June 30,  
     2013     2012  

Theatre Installations:

    

Full new sales and sales-type lease arrangements

     11        11   

New joint revenue sharing arrangements

     18        9   
  

 

 

   

 

 

 

Total new theatres

     29        20   

Upgrades of IMAX theatre systems

     1        —     
  

 

 

   

 

 

 

Total Theatre Installations

     30        20   
  

 

 

   

 

 

 
     As of June 30,  
     2013     2012  

Theatre Backlog:

    

New sales and sales-type lease arrangements

     140        144   

New joint revenue sharing arrangements

     124        135   
  

 

 

   

 

 

 

Total new theatres

     264        279   

Upgrades of IMAX theatre systems

     20        1   
  

 

 

   

 

 

 

Total Theatres in Backlog

     284        280   
  

 

 

   

 

 

 
     As of June 30,  
     2013     2012  

Theatre Network:

    

Commercial Multiplex Theatres:

    

Sales and sales-type lease arrangements

     298        255   

Joint revenue sharing arrangements

     336        274   
  

 

 

   

 

 

 

Total Commercial Multiplex Theatres

     634        529   

Commercial Destination Theatres

     19        20   

Institutional Theatres

     114        114   
  

 

 

   

 

 

 

Total IMAX Theatre Network

     767        663   
  

 

 

   

 

 

 

 

(1) Includes one signing which replaced a theater under an existing arrangement in backlog.
(2) Includes five signings for laser-based digital systems in existing theater locations.
(3) Includes three signings for xenon-based digital systems under short-term operating lease arrangements.

 

4


Additional Information (continued)

2013 DMR Films Announced to Date:

To date, IMAX has announced 34 titles to be released in 2013. The Company released 35 titles in 2012. The Company remains in discussions with virtually every major studio regarding future titles and expects the total number of titles in 2013 to be similar to that in 2012.

 

   

The Grandmaster: The IMAX Experience (Jet Tone Films and Sil-Metropole Organization, January 2013, China only);

 

   

Hansel & Gretel: Witch Hunters: An IMAX 3D Experience (Paramount Pictures, January 2013);

 

   

Journey to the West: Conquering the Demons: An IMAX 3D Experience (Bingo Movie Development Ltd, February 2013, China only);

 

   

Top Gun: An IMAX 3D Experience (Paramount Pictures, February 2013);

 

   

A Good Day to Die Hard: The IMAX Experience (Twentieth Century Fox, February 2013);

 

   

Jack the Giant Slayer: An IMAX 3D Experience (Warner Bros., March 2013);

 

   

Oz: The Great and Powerful: An IMAX 3D Experience (Walt Disney Pictures, March 2013);

 

   

G.I. Joe: Retaliation: An IMAX 3D Experience (Paramount Pictures, March 2013);

 

   

Dragon Ball Z: Battle of the Gods: An IMAX 3D Experience (Toei Animation Company, March 2013, Japan only);

 

   

Jurassic Park: An IMAX 3D Experience (Universal Pictures, April 2013);

 

   

Oblivion: The IMAX Experience (Universal Pictures, April 2013);

 

   

Iron Man 3: An IMAX 3D Experience (Walt Disney Pictures, May 2013);

 

   

Star Trek: Into Darkness: An IMAX 3D Experience (Paramount Pictures, May 2013);

 

   

Fast & Furious 6: The IMAX Experience (Universal, May 2013, international only);

 

   

After Earth: The IMAX Experience (Sony, May 2013);

 

   

Man of Steel: The IMAX Experience (Warner Bros., June 2013);

 

   

World War Z: An IMAX 3D Experience (Paramount Pictures, June 2013, international only);

 

   

Despicable Me 2: An IMAX 3D Experience (Universal Pictures, July 2013, international only);

 

   

White House Down: The IMAX Experience (Colombia Pictures and Sony Pictures, July 2013; international only);

 

   

Man of Tai Chi: The IMAX Experience (China Film Group, Wanda Group and Village Roadshow Pictures, July 2013; China only);

 

   

Pacific Rim: An IMAX 3D Experience (Warner Bros., July 2013);

 

   

The Lone Ranger : The IMAX Experience (Walt Disney Pictures, August 2013; international only);

 

   

Elysium: The IMAX Experience (Sony, August 2013);

 

   

Riddick Sequel: The IMAX Experience (Universal Pictures, September 2013);

 

   

Mortal Instruments: City of Bones: The IMAX Experience (Sony, August 2013; domestic only);

 

   

The Wizard of Oz: An IMAX 3D Experience (Warner Bros., September 2013; domestic only);

 

   

Metallica Through the Never: An IMAX 3D Experience (Picturehouse, September 2013);

 

   

Stalingrad: An IMAX 3D Experience (AR Films, October 2013; Russia and the CIS only );

 

   

Gravity: An IMAX 3D Experience (Warner Bros., October 2013);

 

   

The Young and Prodigious: T.S. Spivet: An IMAX 3D Experience (Gaumont, October 2013; France only);

 

   

Ender’s Game: The IMAX Experience (Lionsgate, November 2013);

 

   

The Hunger Games: Catching Fire: The IMAX Experience (Lionsgate, November 2013);

 

   

The Hobbit: The Desolation of Smaug: An IMAX 3D Experience (Warner Bros., December 2013); and

 

   

Dhoom 3: The IMAX Experience (Yash Raj Films, 2013, India only).

 

5


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars, except per share amounts)

(Unaudited)

 

     Three Months     Six Months  
     Ended June 30,     Ended June 30,  
     2013     2012*     2013     2012*  

Revenues

        

Equipment and product sales

   $ 20,347      $ 17,050      $ 31,026      $ 31,429   

Services

     42,099        34,929        68,958        61,996   

Rentals

     17,823        16,429        27,795        28,899   

Finance income

     2,024        1,802        4,008        3,482   

Other

     —          —          375        —     
  

 

 

   

 

 

   

 

 

   

 

 

 
     82,293        70,210        132,162        125,806   
  

 

 

   

 

 

   

 

 

   

 

 

 

Costs and expenses applicable to revenues

        

Equipment and product sales

     11,416        7,980        16,475        17,075   

Services

     23,126        18,651        38,444        34,271   

Rentals

     4,175        4,746        7,628        8,766   

Other

     —          —          —          —     
  

 

 

   

 

 

   

 

 

   

 

 

 
     38,717        31,377        62,547        60,112   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     43,576        38,833        69,615        65,694   

Selling, general and administrative expenses (including share-based compensation expense of $3.1 million and $5.9 million for the three and six months ended June 30, 2013, respectively (2012 - expense of $3.7 million and $7.5 million, respectively))

     22,110        20,431        39,586        39,599   

Research and development

     3,659        2,465        7,293        5,095   

Amortization of intangibles

     373        190        737        366   

Receivable provisions, net of recoveries

     55        137        55        588   

Impairment of available-for-sale investment

     —          150        —          150   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations

     17,379        15,460        21,944        19,896   

Interest income

     12        27        25        51   

Interest expense

     (348     (476     (693     (1,002
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations before income taxes

     17,043        15,011        21,276        18,945   

Provision for income taxes

     (4,793     (3,732     (5,945     (4,698

Loss from equity-accounted investments

     (434     (245     (654     (704
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 11,816      $ 11,034      $ 14,677      $ 13,543   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share - basic and diluted:

        

Net income per share - basic

   $ 0.18      $ 0.17      $ 0.22      $ 0.21   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share - diluted

   $ 0.17      $ 0.16      $ 0.21      $ 0.20   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of shares outstanding (000’s):

        

Basic

     66,952        65,822        66,799        65,612   

Fully Diluted

     68,893        68,374        68,769        68,190   

Additional Disclosure:

        

Depreciation and amortization

   $ 11,610      $ 9,200      $ 20,201      $ 16,666   

 

* Reflects a revision resulting from an adjustment to reflect an unfunded postretirement obligation of the Company.

 

6


IMAX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars)

(Unaudited)

 

     June 30,     December 31,  
     2013     2012  

Assets

    

Cash and cash equivalents

   $ 20,774      $ 21,336   

Accounts receivable, net of allowance for doubtful accounts of $1,495 (December 31, 2012 — $1,564)

     62,712        42,007   

Financing receivables

     100,088        94,193   

Inventories

     12,770        15,794   

Prepaid expenses

     4,572        3,833   

Film assets

     6,005        3,737   

Property, plant and equipment

     121,859        113,610   

Other assets

     26,126        23,963   

Deferred income taxes

     32,050        36,461   

Goodwill

     39,027        39,027   

Other intangible assets

     27,787        27,911   
  

 

 

   

 

 

 

Total assets

   $ 453,770      $ 421,872   
  

 

 

   

 

 

 

Liabilities

    

Bank indebtedness

   $ 18,000      $ 11,000   

Accounts payable

     18,356        15,144   

Accrued and other liabilities

     66,372        68,695   

Deferred revenue

     73,916        73,954   
  

 

 

   

 

 

 

Total liabilities

     176,644        168,793   
  

 

 

   

 

 

 

Commitments, contingencies and guarantees

    

Shareholders’ equity

    

Capital stock (note 15) common shares — no par value. Authorized — unlimited number.

    

Issued and outstanding — 67,062,106 (December 31, 2012 — 66,482,425)

     320,102        313,744   

Other equity

     32,160        28,892   

Deficit

     (72,489     (87,166

Accumulated other comprehensive loss

     (2,647     (2,391
  

 

 

   

 

 

 

Total shareholders’ equity

     277,126        253,079   
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 453,770      $ 421,872   
  

 

 

   

 

 

 

 

7


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars)

(Unaudited)

 

     Six Months  
     Ended June 30,  
     2013     2012*  

Cash provided by (used in):

    

Operating Activities

    

Net income

   $ 14,677      $ 13,543   

Adjustments to reconcile net income to cash from operations:

    

Depreciation and amortization

     20,201        16,666   

Write-downs, net of recoveries

     55        919   

Change in deferred income taxes

     4,481        3,578   

Stock and other non-cash compensation

     6,317        8,062   

Gain on curtailment of postretirement benefits

     (2,185     —     

Unrealized foreign currency exchange loss (gain)

     874        (720

Loss from equity-accounted investments

     654        704   

Investment in film assets

     (12,033     (11,141

Changes in other non-cash operating assets and liabilities

     (25,021     (11,769
  

 

 

   

 

 

 

Net cash provided by operating activities

     8,040        19,842   
  

 

 

   

 

 

 

Investing Activities

    

Purchase of property, plant and equipment

     (5,054     (1,775

Investment in joint revenue sharing equipment

     (10,393     (13,024

Investment in new business ventures

     (1,000     (381

Acquisition of other intangible assets

     (1,142     (4,223
  

 

 

   

 

 

 

Net cash used in investing activities

     (17,589     (19,403
  

 

 

   

 

 

 

Financing Activities

    

Increase in bank indebtedness

     12,000        9,917   

Repayment of bank indebtedness

     (5,000     (10,000

Common shares issued - stock options exercised

     3,992        5,039   

Credit facility amendment fees paid

     (2,088     —     
  

 

 

   

 

 

 

Net cash provided by financing activities

     8,904        4,956   
  

 

 

   

 

 

 

Effects of exchange rate changes on cash

     83        47   
  

 

 

   

 

 

 

(Decrease) increase in cash and cash equivalents during the period

     (562     5,442   

Cash and cash equivalents, beginning of period

     21,336        18,138   
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 20,774      $ 23,580   
  

 

 

   

 

 

 

 

8


IMAX CORPORATION

SELECTED FINANCIAL DATA

In accordance with United States Generally Accepted Accounting Principles

(in thousands of U.S. dollars)

The Company has seven reportable segments identified by category of product sold or service provided: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production; and other. The IMAX systems segment is comprised of the design, manufacture, sale or lease IMAX theater projection system equipment. The theater system maintenance segment consists of the maintenance of IMAX theater projection system equipment in the IMAX theater network. The joint revenue sharing arrangements segment is comprised of the installation IMAX theater projection system equipment to an exhibitor in exchange for a certain percentage of box-office receipts, concession revenue and in some cases a small upfront or initial payment. The film production and IMAX DMR segment is comprised of the production of films and performance of film re-mastering services. The film distribution segment includes the distribution of films for which the Company has distribution rights. The film post-production segment includes the provision of film post-production and film print services. The other segment includes certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.

 

     Three Months Ended June 30,      Six Months Ended June 30,  
     2013      2012      2013      2012  

Revenue

           

Theater Systems

           

IMAX Systems

           

Sales and sales-type leases(2)

   $ 17,105       $ 14,948       $ 26,902       $ 27,814   

Ongoing rent, fees, and finance income

     3,687         3,099         6,628         5,891   

Other

     4,149         3,057         6,132         5,397   
  

 

 

    

 

 

    

 

 

    

 

 

 
     24,941         21,104         39,662         39,102   
  

 

 

    

 

 

    

 

 

    

 

 

 

Theater system maintenance

     7,952         6,989         15,741         13,836   
  

 

 

    

 

 

    

 

 

    

 

 

 

Joint revenue sharing arrangements

     18,336         15,593         27,712         27,291   
  

 

 

    

 

 

    

 

 

    

 

 

 

Film

           

Production and IMAX DMR

     25,952         19,744         40,307         33,582   

Film distribution and post-production

     5,112         6,780         8,740         11,995   
  

 

 

    

 

 

    

 

 

    

 

 

 
     31,064         26,524         49,047         45,577   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 82,293       $ 70,210       $ 132,162       $ 125,806   
  

 

 

    

 

 

    

 

 

    

 

 

 

Gross margins

           

Theater Systems

           

IMAX systems(1)

           

Sales and sales-type leases(2)

   $ 7,154       $ 8,034       $ 12,462       $ 12,684   

Ongoing rent, fees, and finance income

     3,575         3,073         6,481         5,835   

Other

     622         180         273         (277
  

 

 

    

 

 

    

 

 

    

 

 

 
     11,351         11,287         19,216         18,242   
  

 

 

    

 

 

    

 

 

    

 

 

 

Theater system maintenance

     3,160         2,568         6,214         5,294   
  

 

 

    

 

 

    

 

 

    

 

 

 

Joint revenue sharing arrangements(1)

     13,507         11,117         19,643         19,054   
  

 

 

    

 

 

    

 

 

    

 

 

 

Film

           

Production and IMAX DMR(1)

     14,936         12,358         24,149         20,288   

Film distribution and post-production

     622         1,503         393         2,816   
  

 

 

    

 

 

    

 

 

    

 

 

 
     15,558         13,861         24,542         23,104   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 43,576       $ 38,833       $ 69,615       $ 65,694   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1) IMAX systems include commission costs of $0.4 million and $0.7 million for the three and six months ended June 30, 2013, respectively (2012 — $0.5 million and $1.2 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $0.9 million and $1.1 million for the three and six months ended June 30, 2013, respectively (2012 — $0.7 million and $1.0 million, respectively). Production and IMAX DMR segment margins include marketing costs of $1.4 million and $2.3 million for the three and six months ended June 30, 2013, respectively (2012 — $1.1 million and $1.7 million, respectively). Distribution segment margins include a marketing cost of less than $0.1 million and an expense of $0.1 million for the three and six months ended June 30, 2013, respectively (2012 — expense of $0.4 million and $1.2 million, respectively).
(2) Includes revenue of $3.1 million and a margin loss of $0.3 million in the three and six months ended June 30, 2013, respectively, for 10 theater systems under a digital upgrade arrangement which were previously installed, but revenue recognition was deferred.

 

9


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Non-GAAP Financial Measures:

In this release, the Company presents adjusted EBITDA, adjusted net income and adjusted net income per diluted share as supplemental measures of performance of the Company, which are not recognized under United States generally accepted accounting principles (“GAAP”). The Company presents adjusted EBITDA, adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its share-based compensation and the related tax impact. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted EBITDA, adjusted net income and adjusted net income per diluted share should be considered in addition to, and not as a substitute for, net income and other measures of financial performance reported in accordance with GAAP.

Adjusted EBITDA is calculated on a basis consistent with the Company’s Credit Facility, which refers to Adjusted EBITDA as EBITDA. The Credit Facility provides that the Company will be required to maintain a Fixed Charge Coverage Ratio (as defined in the Credit Agreement) of not less than 1.1:1.0. The Company will also be required to maintain minimum EBITDA (as defined in the Credit Agreement) of $70.0 million between closing and September 30, 2013, which requirement increases to $80.0 million on December 31, 2013, $90.0 million on December 31, 2014, and $100.0 million on December 31, 2015. The Company must also maintain a Maximum Total Leverage Ratio (as defined in the Credit Agreement) of 2.5:1.0 between closing and September 30, 2013, which requirement decreases to (i) 2.25:1.0 on December 31, 2013; (ii) 2.00:1:0 on December 31, 2014; and (iii) 1.75:1.0 on December 31, 2015. The ratio of total debt to EBITDA was 0.17:1 as at June 30, 2013, where Total Debt (as defined in the Credit Agreement) is the sum of all obligations evidenced by notes, bonds, debentures or similar instruments and was $18.0 million. EBITDA is calculated as follows:

 

     Three months ended      Twelve months ended  
     June 30, 2013      June 30, 2013  
(In thousands of U.S Dollars)              

Net income

   $ 11,816       $ 42,472   

Add:

     

Loss from equity accounted investments

     434         1,312   

Provision for income taxes

     4,793         16,327   

Interest expense, net of interest income(1)

     336         320   

Depreciation and amortization, including film asset amortization

     11,483         36,012   

Write-downs net of recoveries including asset impairments and receivable provisions

     55         743   

Stock and other non-cash compensation

     3,317         12,474   

Gain on curtailment of postretirement benefits

     —           (2,185
  

 

 

    

 

 

 
   $ 32,235       $ 107,475   
  

 

 

    

 

 

 

 

(1) Includes $0.1 million and $0.3 million of amortization of deferred financing costs charged to interest expense for the three and twelve months ended June 30, 2013, respectively.

 

10


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended June 30, 2013 vs. 2012:

The Company reported net income of $11.8 million or $0.18 per basic share and $0.17 per diluted share for the second quarter of 2013, as compared to net income of $11.0 million or $0.17 per basic and $0.16 per diluted share for the second quarter of 2012. Net income for the second quarter of 2013 includes a $3.1 million charge, or $0.05 per diluted share, for stock-based compensation (2012 - $3.7 million or $0.06 per diluted share). Adjusted net income, which consists of net income excluding stock-based compensation expense and the related tax benefit, was $15.0 million, or $0.22 per diluted share, in the second quarter of 2013, as compared to adjusted net income of $14.7 million, or $0.22 per diluted share, for the second quarter of 2012. A reconciliation of net income, the most directly comparable U.S. GAAP measure, to adjusted net income and adjusted net income per diluted share is presented in the table below:

 

     Three Months Ended      Three Months Ended  
     June 30, 2013      June 30, 2012  
     Net Income      Diluted EPS      Net Income      Diluted EPS  

Reported net income

   $ 11,816       $ 0.17       $ 11,034       $ 0.16   

Adjustments:

           

Stock-based compensation

     3,125         0.05         3,694         0.06   

Tax benefit of items listed above

     31         —           7         —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted net income

   $ 14,972       $ 0.22       $ 14,735       $ 0.22   
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted average diluted shares outstanding

        68,893            68,374   
     

 

 

       

 

 

 

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Six Months Ended June 30, 2013 vs. 2012:

The Company reported net income of $14.7 million or $0.22 per basic share and $0.21 per diluted share for the six months ended June 30, 2013, as compared to net income of $13.5 million or $0.21 per basic and $0.20 per diluted share for the six months ended June 30, 2012. Net income for the six months ended June 30, 2013 includes a $5.9 million charge, or $0.09 per diluted share, for stock-based compensation (2012 – $7.5 million or $0.11 per diluted share). Adjusted net income, which consists of net income excluding stock-based compensation expense and the related tax expense, was $20.5 million, or $0.30 per diluted share, in the six months ended June 30, 2013, as compared to adjusted net income of $20.8 million, or $0.31 per diluted share, for the six months ended June 30, 2012. A reconciliation of net income, the most directly comparable U.S. GAAP measure, to adjusted net income and adjusted net income per diluted share is presented in the table below:

 

     Six Months      Six Months  
     Ended June 30, 2013      Ended June 30, 2012  
     Net Income     Diluted EPS      Net Income     Diluted EPS  

Net income

   $ 14,677      $ 0.21       $ 13,543      $ 0.20   

Add:

         

Stock-based compensation

     5,933        0.09         7,496        0.11   

Tax expense on items listed above

     (74     —           (194     —     
  

 

 

   

 

 

    

 

 

   

 

 

 

Adjusted net income

   $ 20,536      $ 0.30       $ 20,845      $ 0.31   
  

 

 

   

 

 

    

 

 

   

 

 

 

Weighted average diluted shares outstanding

       68,769           68,190   
    

 

 

      

 

 

 

 

11


Free Cash Flow:

Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company’s after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:

 

     Six Months Ended  
(In thousands of U.S. Dollars)    June 30, 2013  

Net cash provided by operating activities

   $ 8,040  

Net cash (used in) investing activities

     (17,589
  

 

 

 

Free cash flow

   $ (9,549
  

 

 

 

 

12